Management of Stage IIIA (N2) Non–Small Cell Lung Cancer

Erin A. Gillaspie; Dennis A. Wigle

doi:10.1016/j.thorsurg.2016.04.001

Management of Stage IIIA (N2) Non–Small Cell Lung Cancer

Erin A. Gillaspie, Dennis A. Wigle

General Thoracic Surgery

Research output: Contribution to journal › Review article › peer-review

12 Scopus citations

Abstract

There is no consensus as to the optimal management of IIIA (N2) non–small cell lung cancer, nor for the role of surgery in treating this disease stage. Clinical trial evidence struggles to keep up with technology advancement and the evolution of expert opinion. Despite advances in chemotherapeutic regimens, methods of delivery for radiation, and less invasive surgical techniques, survival for patients with stage IIIA-N2 malignancies remains poor. Further developments in both will stimulate and maintain controversy in the field for years to come.

Original language	English (US)
Pages (from-to)	271-285
Number of pages	15
Journal	Thoracic Surgery Clinics
Volume	26
Issue number	3
DOIs	https://doi.org/10.1016/j.thorsurg.2016.04.001
State	Published - Aug 1 2016

Keywords

Adjuvant
N2
Neoadjuvant
Non–small cell lung cancer
PORT
Stage IIIA
Surgery

ASJC Scopus subject areas

Surgery
Pulmonary and Respiratory Medicine

Access to Document

10.1016/j.thorsurg.2016.04.001

Cite this

@article{da7da40ba9284712a712a9b9c053b50f,

title = "Management of Stage IIIA (N2) Non–Small Cell Lung Cancer",

abstract = "There is no consensus as to the optimal management of IIIA (N2) non–small cell lung cancer, nor for the role of surgery in treating this disease stage. Clinical trial evidence struggles to keep up with technology advancement and the evolution of expert opinion. Despite advances in chemotherapeutic regimens, methods of delivery for radiation, and less invasive surgical techniques, survival for patients with stage IIIA-N2 malignancies remains poor. Further developments in both will stimulate and maintain controversy in the field for years to come.",

keywords = "Adjuvant, N2, Neoadjuvant, Non–small cell lung cancer, PORT, Stage IIIA, Surgery",

author = "Gillaspie, {Erin A.} and Wigle, {Dennis A.}",

note = "Publisher Copyright: {\textcopyright} 2016 Elsevier Inc.",

year = "2016",

month = aug,

day = "1",

doi = "10.1016/j.thorsurg.2016.04.001",

language = "English (US)",

volume = "26",

pages = "271--285",

journal = "Thoracic Surgery Clinics",

issn = "1547-4127",

publisher = "W.B. Saunders Ltd",

number = "3",

}

TY - JOUR

T1 - Management of Stage IIIA (N2) Non–Small Cell Lung Cancer

AU - Gillaspie, Erin A.

AU - Wigle, Dennis A.

PY - 2016/8/1

Y1 - 2016/8/1

N2 - There is no consensus as to the optimal management of IIIA (N2) non–small cell lung cancer, nor for the role of surgery in treating this disease stage. Clinical trial evidence struggles to keep up with technology advancement and the evolution of expert opinion. Despite advances in chemotherapeutic regimens, methods of delivery for radiation, and less invasive surgical techniques, survival for patients with stage IIIA-N2 malignancies remains poor. Further developments in both will stimulate and maintain controversy in the field for years to come.

AB - There is no consensus as to the optimal management of IIIA (N2) non–small cell lung cancer, nor for the role of surgery in treating this disease stage. Clinical trial evidence struggles to keep up with technology advancement and the evolution of expert opinion. Despite advances in chemotherapeutic regimens, methods of delivery for radiation, and less invasive surgical techniques, survival for patients with stage IIIA-N2 malignancies remains poor. Further developments in both will stimulate and maintain controversy in the field for years to come.

KW - Adjuvant

KW - N2

KW - Neoadjuvant

KW - Non–small cell lung cancer

KW - PORT

KW - Stage IIIA

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=84990866185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84990866185&partnerID=8YFLogxK

U2 - 10.1016/j.thorsurg.2016.04.001

DO - 10.1016/j.thorsurg.2016.04.001

M3 - Review article

C2 - 27427522

AN - SCOPUS:84990866185

SN - 1547-4127

VL - 26

SP - 271

EP - 285

JO - Thoracic Surgery Clinics

JF - Thoracic Surgery Clinics

IS - 3

ER -

Management of Stage IIIA (N2) Non–Small Cell Lung Cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this